Filing Details
- Accession Number:
- 0001179110-10-012310
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2010-08-05 13:00:00
- Reporting Period:
- 2010-08-03
- Filing Date:
- 2010-08-05
- Accepted Time:
- 2010-08-05 18:59:59
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1235010 | Momenta Pharmaceuticals Inc | MNTA | Biological Products, (No Disgnostic Substances) (2836) | 043561634 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1229450 | A Craig Wheeler | C/O Momenta Pharmaceuticals, Inc. 675 West Kendall Street Cambridge MA 02142 | President | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2010-08-03 | 25,683 | $22.06 | 444,786 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-04 | 12,445 | $20.41 | 432,341 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2010-08-05 | 3,700 | $17.67 | 428,641 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Footnotes
- This sale was effected pursuant to a rule 10b5-1 trading plan adopted by the reporting person on December 12, 2007
- This transaction was executed in multiple trades at prices ranging from $21.92 to $22.30. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
- This transaction was executed in multiple trades at prices ranging from $20.26 to $20.91. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
- This transaction was executed in multiple trades at prices ranging from $17.60 to $17.72. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected
Billionaire Hedge Funds
